Cryoport Inc
For the period ended Dec 31, 2023. Filed Mar 13, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 13, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
| Cryoport, Inc. | |
| By: | /s/ JERRELL W. SHELTON |
| Jerrell W. Shelton | |
| President and Chief Executive Officer |
Date: March 13, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
| Signature | Title | Date | |||
|---|---|---|---|---|---|
| | | | |||
| /s/ JERRELL W. SHELTON | | President, Chief Executive Officer and Director | | March 13, 2024 | |
| Jerrell W. Shelton | | (Principal Executive Officer) | | | |
| | | | |||
| /s/ ROBERT S. STEFANOVICH | | Chief Financial Officer | | March 13, 2024 | |
| Robert S. Stefanovich | | (Principal Financial and Accounting Officer) | | | |
| | | | |||
| /s/ RICHARD BERMAN | | Director | | March 13, 2024 | |
| Richard Berman | | | | ||
| | | | |||
| /s/ DANIEL M. HANCOCK | | Director | | March 13, 2024 | |
| Daniel M. Hancock | | | | ||
| | | | |||
| /s/ ROBERT HARIRI, M.D., PH.D. | | Director | | March 13, 2024 | |
| Robert Hariri, M.D., Ph.D. | | | | ||
| | | | |||
| /s/ RAMKUMAR MANDALAM, PH.D. | | Director | | March 13, 2024 | |
| Ramkumar Mandalam, Ph.D. | | | | ||
| | | | | | |
| /s/ RAM JAGANNATH | | Director | | March 13, 2024 | |
| Ram Jagannath | | | | | |
| | | | | | |
| /s/ LINDA BADDOUR | | Director | | March 13, 2024 | |
| Linda Baddour | | | | | |
Consolidated Financial Statements
As of December 31, 2023 and 2022
Years Ended December 31, 2023, 2022 and 2021
Consolidated Financial Statements
INDEX TO FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34) | F-2 |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 42) | F-5 |
| Consolidated Balance Sheets as of December 31, 2023 and 2022 | F-6 |
| Consolidated Statements of Operations for the years ended December 31, 2023, 2022 and 2021 | F-7 |
| Consolidated Statements of Comprehensive Loss for the years ended December 31, 2023, 2022 and 2021 | F-8 |
| Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2023, 2022 and 2021 | F-9 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2023, 2022 and 2021 | F-10 |
| Notes to Consolidated Financial Statements | F-11 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.